MedTrace Logo

Theta Healing-Based Intervention in Women With Polycystic Ovary Syndrome

NCT07630441 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2026-06-05

No results posted yet for this study

Summary

This randomized controlled study aims to evaluate the effect of a Theta Healing-based intervention on fertility concerns, self-compassion, and body image in women diagnosed with Polycystic Ovary Syndrome (PCOS). Participants will be randomly assigned to intervention and control groups. The intervention group will receive a structured 5-day Theta Healing-based online intervention program, while the control group will continue routine care. Outcome measures will be assessed at baseline and 6 weeks after the intervention.

Conditions

  • Polycystic Ovarian Syndrome (PCOS)
  • Infertility
  • Psychological Stress

Interventions

BEHAVIORAL

Theta Healing-Based Intervention

The intervention consists of a structured 5-day Theta Healing-based online program including guided meditation, relaxation exercises, visualization, positive affirmations, subconscious awareness practices, and self-compassion-focused exercises. Audio recordings will be delivered daily via WhatsApp, and a final online group session will be conducted on the fifth day by a certified Theta Healing practitioner.

Sponsors & Collaborators

  • Ankara Medipol University

    lead OTHER

Principal Investigators

  • Seniha Balci Cebeci, Research Assistant · Ankara Medipol University

  • Tugba Tahta, Assistant Professor · Ankara Medipol University

  • Sinem Ceylan, Assistant Professor · Saglik Bilimleri Universitesi

  • Ozge Aydogan Asir, Assistant Professor · Ankara Medipol University

  • Gulten Guvenc, Professor · Saglik Bilimleri Universitesi

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-08
Primary Completion
2026-07-24
Completion
2026-09-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07630441 on ClinicalTrials.gov